StockData

Intercure Ltd. (INCR) stock

INCRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 30, 2026Score 3/30
$3.61−0.02 (-0.55%)

Close on Nov 17, 2026Market cap $197.40MP/E –Yield –

Intercure operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

For fiscal 2025 it was -27.24M ILS. The highest annual figure on record is 50.63M ILS in fiscal 2022.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-27.24M ILS–
FY2024Dec 31, 2024-67.21M ILS–
FY2023Dec 31, 2023-41.57M ILS-182.1%
FY2022Dec 31, 202250.63M ILS+79.6%
FY2021Dec 31, 202128.19M ILS–
FY2020Dec 31, 2020-38.40M ILS–
FY2019Dec 31, 2019-3.42M ILS–

More Intercure figures

See a number that looks wrong?